Definitive Healthcare (NASDAQ:DH) Issues Q1 2025 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its first quarter 2025 earnings guidance on Thursday. The company provided EPS guidance of 0.020-0.020 for the period, compared to the consensus EPS estimate of 0.070. The company issued revenue guidance of $55.5 million-$57.0 million, compared to the consensus revenue estimate of $60.0 million. Definitive Healthcare also updated its FY 2025 guidance to 0.190-0.220 EPS.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on DH. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Stephens started coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price target on the stock. Finally, Barclays restated an “underweight” rating and set a $4.00 price objective on shares of Definitive Healthcare in a research report on Monday, January 13th. Two analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $5.72.

Definitive Healthcare Trading Down 3.5 %

NASDAQ DH traded down $0.18 during mid-day trading on Thursday, reaching $4.92. 671,754 shares of the stock were exchanged, compared to its average volume of 764,583. The business’s fifty day simple moving average is $4.63 and its 200 day simple moving average is $4.47. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The stock has a market capitalization of $568.37 million, a PE ratio of -1.59, a PEG ratio of 4.06 and a beta of 1.45. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $10.62.

Insider Transactions at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the sale, the insider now directly owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 14.84% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.